Association of Simvastatin and Hyperlipidemia with Periodontal Status and Bone Metabolism Markers.

Within the limits of this study, our findings suggest that the intake of simvastatin is associated with increasing serum OPG concentrations and this could have a protective effect against bone destruction and periodontal clinical attachment loss.

The baseline systemic inflammatory state of hyperlipidemic patients is indicated by their increased erythrocyte sedimentation rate.

Autor: Magán-Fernández A, Papay-Ramírez L, Tomás J, Marfil-Alvarez R, Rizzo M, Bravo M, Mesa F.

Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada